| |||
News EssentialsThe Newsroom TopicsIRS Resources | Issue Number: IR-2023-141Inside This IssueTreasury and IRS issue guidance relating to section 5000D of the Internal Revenue Code WASHINGTON — The Department of the Treasury and the Internal Revenue Service today issued guidance for manufacturers, producers and importers of certain drugs regarding the tax imposed by section 5000D of the Internal Revenue Code. Section 5000D was enacted as part of the Inflation Reduction Act. Notice 2023-52 announces that the Treasury Department and IRS intend to issue proposed regulations under section 5000D. Specifically, the notice proposes that future regulations will provide:
The IRS maintains a page on IRS.gov with news and technical guidance related to all aspects of the Inflation Reduction Act.
Thank you for subscribing to the IRS Newswire, an IRS e-mail service. If you know someone who might want to subscribe to this mailing list, please forward this message to them so they can subscribe. This message was distributed automatically from the mailing list IRS Newswire. Please Do Not Reply To This Message. |
No comments:
Post a Comment